Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts

Biochemical Pharmacology

Volumn 51, Issue 5, 1996, Pages 577-584

  Windmeier, C ^a   Gressner, A M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

fat storing cells; inhibition; liver fibrogenesis; matrix synthesis; pentoxifylline

Indexed keywords

ALPHA ACTIN; FIBRONECTIN; GLYCOSAMINOGLYCAN; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE; RETINOL PALMITATE; SULFUR 35;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROGENESIS; IMMUNOFLUORESCENCE; LIVER CELL; LIVER FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE;

EID: 0029875305     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(95)02173-6     Document Type: Article

References (44)

1. Burt AD, Liver fibrosis. Br Med J 305: 537-538, 1992.
2. Friedman SL, The cellular basis of hepatic fibrosis. N Engl J Med 328: 1828-1835, 1993.
3. Gressner AM, Liver fibrosis: Perspectives in pathobiochemical research and clinical outlook. Eur J Cliln Chem Clin Biochem 29: 293-311, 1991.
4. Aterman K, The parasinusoidal cells of the liver: a historical account. Histochem J 18: 279-305, 1986.
5. Ramadori G, The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. Virchows Arch B Cell Pathol 61: 147-158, 1991.
6. Blomhoff R and Wake K, Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J 5: 271-277, 1991.
7. Gressner AM, Perisinusoidal lipocytes and fibrogenesis. Gut 35: 1331-1333, 1994.
8. Rockey DC, Boyles JK, Gabbiani G and Friedman SL, Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24: 193-203, 1992.
9. Bachem MG, Meyer DH, Schäfer W, et al. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulators changes with cell transdifferentiation into myofibroblast-like cells. In: Cellular and Molecular Aspects of Cirrhosis (Eds. Clement B, Guillouzo A). Colloque INSERM/John Libbey Eurotext Ltd., London, pp. 223-226, 1992.
10. Friedman SL, Cellular sources of collagen and regulation of collagen production in liver. Sem Liver Dis 10: 20-29, 1990.
11. Gressner AM, and Bachem MG, Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Sem Liver Dis 10: 30-46, 1990.
12. Gressner AM, Activation of proteoglycan synthesis in injured liver - A brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem 32: 225-237, 1994.
13. Chojkier M and Brenner DA, Therapeutic strategies for hepatic fibrosis. Hepatology 8: 176-182, 1988.
14. Wu J, and Danielsson A, Inhibition of hepatic fibrogenesis; A review of pharmacologic candidates. Scand J Gastroenterol 29: 385-391, 1994.
15. Berman B and Duncan MR, Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. J Invest Dermatol 123: 339-346, 1990.
16. Berman B, Matthew R and Duncan MR, Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 92: 605-609, 1989.
17. Duncan MR, Hasan A, and Berman B, Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: Evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol 104: 282-286, 1995.
18. Ward A and Clissold SP, Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34: 50-97, 1987.
19. Peterson TC, Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 17: 486-493, 1993.
20. Boigk G, Raetsch C, Stroeter L, Waldschmidt J, Herbst H, Riecken EO and Schuppan D, Antifibrotic effect of pentoxifyl-line in rat biliary fibrosis due to bile duct obstruction. J Hepatol 23(Suppl 1): 142, 1995.
21. Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellinck P and Wisse E, In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 9: 59-68, 1989.
22. Gressner AM, Time-related distribution profiles of sulfated glycosaminoglycans in cells, cell surfaces and media of cultured rat liver fat-storing cells. Proc Soc Exp Biol Med 196: 307-315, 1991.
23. Bachem MG, Meyer D, Schäfer W, Riess U, Melchior RF, Sell KM and Gressner AM, The response of rat liver persinusoidal lipocytes to polypeptide growth regulators changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol 18: 40-52, 1993.
24. Knook DL and De Leeuw AM, Isolation and characterization of fat storing cells from the rat liver. In: Sinusoidal Liver Cells (Eds. Knook DL and Wisse E), pp. 45-52, Elsevier Biochemical Press, Rijswijk, Netherlands, 1982.
25. Schäfer S, Zerbe O and Gressner AM, The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7: 680-687, 1987.
26. Yokoi Y, Namihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S and Usui K, Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 4: 709-714, 1984.
27. Chen W, Gendrault JL, Steffan AM, Jeaddidier E and Kirn A, Isolation, culture and main characteristics of mouse fat-storing cells: interaction with viruses. Hepatology 9: 352-362, 1989.
28. Vuilleumier JP, Keller HE, Glysel D and Hunziker F, Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I: The fat-soluble A and E, and beta-carotene. Int J Vit Nutr Res 53: 265-272, 1983.
29. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T and Gressner AM, Tumor necrosis factor alpha (TNFalpha) and transforming growth factor betal (TGFbeta1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virch Arch B Cell Pathol 63: 123-130, 1993.
30. Gressner AM and Althaus M, Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis. Biochem Pharmacol 40: 1953-1962, 1990.
31. Kropf J, Quitte E and Gressner AM, Time-resolved immunofluorometric assay with measurement of a europium chelate in solution: application for sensitive determination of fibronectin. Analyt Biochem 197: 258-265, 1991.
32. Labarca C and Paigen K, A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
33. Rotman B and Papermaster BW, Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci USA 55: 134-141, 1966.
34. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ and Sobin LH, The morphology of cirrhosis. J Clin Pathol 31: 395-414, 1978.
35. Gressner AM and Bachem MG, Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm. Ann Biol Clin 52: 205-226, 1994.
36. Sullivan GW, Carper HT, Novick WJ and Mandell GL, Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 56: 1722-1729, 1988.
37. Doherty GM, Jensen JC, Alexander H, Buresh CM and Norton J, Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110: 192-198, 1991.
38. Friedman SL and Arthur JP, Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. J Clin Invest 84: 1780-1785, 1989.
39. Peterson TC, Isbrucker RA and Hooper ML, In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 28: 259-270, 1994.
40. Pinzani M, DeFranco R, Caligiuri A, Gentilini A, Casini A, Carloni V, Marra F, Romanelli RG and Gentilini P, Cellular basis for the use of pentoxifylline (PTX) as a potential antifibrogenic agent. J Hepatol 23 (Suppl 1): 81, 1995.
41. Mak KM, Leo MA and Lieber CS, Alcoholic liver injury in baboons: Transformation of lipocytes to transitional cells. Gastroenterology 87: 188-200, 1984.
42. Horn T, Junge J and Christoffersen P, Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol 3: 333-340, 1986.
43. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y and Hara H, Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Archiv 424: 249-256, 1994.
44. Hinze JH, Grigoleit HG and Rethy B, Bioavailability and pharmacokinetics of pentoxifylline from trental 400 in man. Pharmatherapeutica 1: 160-171, 1976.